{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:20:21Z","timestamp":1791829221451,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.clinthera.2011.02.007","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T17:11:52Z","timestamp":1302801112000},"page":"159-166","source":"Crossref","is-referenced-by-count":54,"title":["Efficacy of Pregabalin for Peripheral Neuropathic Pain: Results of an 8-Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct00301223","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yuzhou","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.02.007_bib1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1526-4637.2007.00347.x","article-title":"Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options","volume":"9","author":"Veves","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.clinthera.2011.02.007_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(96)03122-3","article-title":"Pain and its persistence in herpes zoster","volume":"67","author":"Dworkin","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.02.007_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0304-3959(88)90139-X","article-title":"Post-herpetic neuralgia: 208 cases","volume":"35","author":"Watson","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.02.007_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00023210-200822050-00005","article-title":"An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy","volume":"22","author":"Zin","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2011.02.007_bib5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"issue":"Suppl 10","key":"10.1016\/j.clinthera.2011.02.007_bib6","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2011.02.007_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: An evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.02.007_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.02.007_bib9","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.02.007_bib10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.02.007_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.02.007_bib12","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2165\/00003495-200464240-00006","article-title":"Pregabalin: In the treatment of painful diabetic peripheral neuropathy","volume":"64","author":"Frampton","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2011.02.007_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/11203750-000000000-00000","article-title":"Pregabalin: In the treatment of postherpetic neuralgia","volume":"26","author":"McKeage","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinthera.2011.02.007_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2011.02.007_bib15","series-title":"The Design of Analgesic Clinical Trials","first-page":"193","article-title":"Neuropathic pain syndromes","volume":"Vol 18","author":"Max","year":"1991"},{"key":"10.1016\/j.clinthera.2011.02.007_bib16","series-title":"Handbook of Pain Assessment","first-page":"135","article-title":"Self-report scales and procedures for assessing pain in adults","author":"Jensen","year":"1992"},{"key":"10.1016\/j.clinthera.2011.02.007_bib17","series-title":"Lyrica (pregabalin) Capules","year":"2010"},{"key":"10.1016\/j.clinthera.2011.02.007_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clin J Pain"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T11:23:47Z","timestamp":1543836227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0149291811000890"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.02.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}